Philip L Johnson Jazz Pharmaceuticals PLC (JAZZ) insider trading activity
Philip L Johnson is EVP & Chief Financial Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 50,060 shares of JAZZ, which is worth approximately $5.15 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 1,149 shares (Ordinary Shares) at a price of $138.95 per share, resulting in proceeds of $159,653. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
50.1K
79.22%
3M change
79.22%
12M change
Total Value Held
$5.15 Million
Philip L Johnson Transaction History
PLJ
Philip L Johnson
EVP & Chief Financial Officer
Dublin 4, L2